MaxiVision Ocular Formula AREDS2

$34.95 / month

MaxiVision AREDS2 Ocular Formulation

  • 2X Lutein and Zeaxanthin – Double the levels of other leading brands
  • Plus – Proprietary blend of key eye nutrients*
  • Vitamin C
  • Vitamin D
  • Vitamin E
  • Zinc
  • Copper
  • Lutein
  • Zeaxanthin
  • L-taurine

SKU: MA9997 Category:

Description

Supplement Description

MaxiVision Ocular Formula AREDS2 is an Eye Vitamin and Mineral Supplement – with 10 mg Lutein and 2 mg Zeaxanthin

Supplement Facts

Vitamin C.                               500 mg.     833%
Vitamin D.                               3600 IU.     150%
Vitamin E.                                400 IU.     1333%
Zinc.                                        25 mg.        167%
Copper.                                   1.6 mg.         80%
Lutein (contains FloraGLO®). 20 mg
Zeaxanthin.                               4 mg
Proprietary Blend:                  160 mg
N-acetyl-cysteine
Acetyl-L-carnitine
Taurine (as L-taurine base)
Bilberry extract, powdered (fruit)
Alpha lipoic acid
Coenzyme Q10 (ubiquinone)
Quercetin
Resveratrol

Other Ingredients

Ascorbic acid, d-alpha tocopheryl acetate, vegetable capsule (hypromellose, titanium dioxide (for color)), lutein, zinc amino acid chelate, mixed tocopherols, zeaxanthin, N-acetyl-L-cysteine, acetyl-L-carnitine hydrochloride, L-taurine, resveratrol, alpha lipoic acid, bilberry (fruit) extract, silicon dioxide, ubiquinone, quercetin, cupric oxide, and cholecalciferol

Serving Size: 2 capsules

Servings per Bottle: 30

Suggested Use

Directions: Take two capsules per day during a meal, or as directed by your health care professional.

Notes

Contains Fish (cod, pollack, haddock, hake, cusk, redfish, sole, flounder) soy. Contains Natural Source Vitamin E.

Do not use MaxiVision Ocular Formula AREDS2 if the inner safety seal is broken. Keep out of reach of children.

Vitamin & Me

@vitaminandme

Download eatclean30

Enter your email to receive eatclean30 and the latest news and updates from 

Vitamin and Me. 

You have Successfully Subscribed!